BioWorld Asia

Dec. 13, 2006

View Archived Issues

Blindness Gene Identified In Chickens Could Have Impact

Novexel Licenses Aminocandin From Indevus Pharmaceuticals

Belgium's ThromboGenics In Novel Biotech Deal With India

Trophos Announces Plans For ALS TRO19622 Phase II/III Trial

Actelion Shares On Rise As Actelion-1 Now In Phase III

Peptech Ponders Various Ways Of Spending £71.3M

Genfit To List Shares On Alternext Market In Paris

PanGenetics In Deals With Schering-Plough, LayLine

Other News To Note

Newron Raises CHF118.12M In Swiss Initial Public Offering

Shares in Newron Pharmaceuticals SpA opened on the Swiss Stock Exchange in Zurich at CHF58 (US$48.20) Tuesday, more than 5 percent above its initial public offering price of CHF55 per share. (BioWorld International) Read More

Pharminox, Schering-Plough Enter Deal Worth Up To $40M

Today's news in brief

BioWorld

BioWorld briefs for March 13, 2026.

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 10, 2026

MSD synthesizes α-synuclein PET agents

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...

Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

BioWorld Science

Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...